Rising prevalence of colorectal cancer and other endoscopy-related diseases to boost the growth of endoscope reprocessing device market.
Market Overview:
Endoscope reprocessing devices are those which are made to kill the organisms in the reusable endoscopes using high disinfectants or liquid chemical solutions to expose the exterior surfaces and the interior channels. Manual cleaning, sterilization, documentation, leak testing and pre –cleaning are some of the steps performed in endoscopy reprocessing.
Competitive Landscape:
The major players operating the endoscope reprocessing device market are STERIS Plc., Cilag GmbH International, Steelco S.p.A., Minntech Corp PENTAX Medical, Medivators Inc., Wassenburg Medical B.V., Soluscope, ENDO-TECHNIK W.Griesat GmbH, Johnson & Johnson and Getinge AB.
Key Market Drivers:
Rising prevalence of colorectal cancer and other endoscopy-related diseases are anticipated to augment the growth of the global endoscope reprocessing device market. For instance, as per the American Cancer Society, nearly 97,220 people are diagnosed with colorectal cancer and 43,030 rectal cancer by the end of 2018.
Furthermore, increasing cardiovascular diseases which are treated with using ERs is anticipated to boost the growth of the global endoscope reprocessing device market. For instance, as per OECD, 45,307 people have undergone the coronary heart bypass surgery/operation in Germany as of 2018.
Covid-19 Impact Analysis:
During the pandemic, along with the sterilization the ERs have also increased as the reprocessors have been a crucial part for the endoscopy surgeries which led to the growth of the global endoscope reprocessing device market.
Key Takeaways:
The global endoscope reprocessing device market is expected to exhibit a CAGR of XX % during the forecast period due to frequent approvals, quick launches of products. For instance, in April 2019, Advanced Sterilization Products gained US. FDA, launched for the ASP AEROFLEX automated endoscopes reprocessors.
Among Regions North America, Asia Pacific and Europe are anticipated to witness robust growth in the global endoscope reprocessing device market due to increasing prevalence of diseases, frequent approvals. As per the Globocan, 3,244 people suffer from stomach cancer in Canada and 5,139 people suffer from pancreatic cancer.
